SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001628280-21-000469
Filing Date
2021-01-15
Accepted
2021-01-14 18:11:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B7 imvtsecondaryfinalprospect.htm 424B7 184756
2 image_21.jpg GRAPHIC 35648
  Complete submission text file 0001628280-21-000469.txt   231812
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 424B7 | Act: 33 | File No.: 333-251865 | Film No.: 21530003
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences